(DERMALIX) (Patent number: PCT/TR2014/000251) is a bioactive wound dressing that was developed by Ege University School of Pharmacy Department of Pharmaceutical Technology. This dressing has been categorised as Class III medical device. This clinical study will be conducted in patients with diabetic foot ulcers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
48
Standard dressing is applied for treatment of diabetic foot ulcers
DERMALIX, a class III Medical Device will be applied in addition to standard dressing
Ege University School of Medicine
Izmir, Turkey (Türkiye)
Recovery of the wound 100%
The wound will be completely recovered
Time frame: 1 month
Recovery of the wound 80%
The wound will be recovered by 80%
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.